HK1197232A1 - Serine/threonine pak1 inhibitors / pak1 - Google Patents

Serine/threonine pak1 inhibitors / pak1

Info

Publication number
HK1197232A1
HK1197232A1 HK14110532A HK14110532A HK1197232A1 HK 1197232 A1 HK1197232 A1 HK 1197232A1 HK 14110532 A HK14110532 A HK 14110532A HK 14110532 A HK14110532 A HK 14110532A HK 1197232 A1 HK1197232 A1 HK 1197232A1
Authority
HK
Hong Kong
Prior art keywords
pak1
threonine
serine
inhibitors
pak1 inhibitors
Prior art date
Application number
HK14110532A
Other languages
English (en)
Chinese (zh)
Inventor
Ignacio Aliagas-Martin
James Crawford
Wendy Lee
Simon Mathieu
Joachim Rudolph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1197232A1 publication Critical patent/HK1197232A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
HK14110532A 2011-08-25 2014-10-22 Serine/threonine pak1 inhibitors / pak1 HK1197232A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161527453P 2011-08-25 2011-08-25
PCT/EP2012/066468 WO2013026914A1 (en) 2011-08-25 2012-08-24 Serine/threonine pak1 inhibitors

Publications (1)

Publication Number Publication Date
HK1197232A1 true HK1197232A1 (en) 2015-01-09

Family

ID=46799208

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14110532A HK1197232A1 (en) 2011-08-25 2014-10-22 Serine/threonine pak1 inhibitors / pak1

Country Status (11)

Country Link
US (1) US8637537B2 (xx)
EP (1) EP2748159A1 (xx)
JP (1) JP2014524456A (xx)
KR (1) KR20140062079A (xx)
CN (1) CN104024248A (xx)
BR (1) BR112014003997A2 (xx)
CA (1) CA2844729A1 (xx)
HK (1) HK1197232A1 (xx)
MX (1) MX2014002208A (xx)
RU (1) RU2014109897A (xx)
WO (1) WO2013026914A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ700332A (en) 2010-03-30 2017-06-30 Verseon Corp Multisubstituted aromatic compounds as inhibitors of thrombin
KR102091894B1 (ko) * 2012-05-03 2020-03-20 제넨테크, 인크. Lrrk2 조절제로서의 피라졸 아미노피리미딘 유도체
CN103724276A (zh) * 2013-12-13 2014-04-16 成都丽璟科技有限公司 一种由硝基苯胺制备苯并咪唑类化合物的新方法
WO2016025641A1 (en) * 2014-08-13 2016-02-18 Celgene Avilomics Research, Inc. Combinations of an erk inhibitor and an egfr inhibitor and related methods
SI3261639T1 (sl) * 2015-02-27 2023-01-31 Verseon International Corporation Substituirane pirazolne spojine kot zaviralci serinskih proteaz
WO2017144546A1 (en) 2016-02-23 2017-08-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of nasopharyngeal carcinoma
CN109311874B (zh) 2016-04-20 2021-07-30 百时美施贵宝公司 经取代的二环杂环化合物
US20200321533A1 (en) * 2016-05-24 2020-10-08 President And Fellows Of Harvard College Compounds for organic light emitting diode materials
WO2018108627A1 (de) 2016-12-12 2018-06-21 Bayer Cropscience Aktiengesellschaft Verwendung substituierter indolinylmethylsulfonamide oder deren salze zur steigerung der stresstoleranz in pflanzen
US20220235013A1 (en) 2017-03-21 2022-07-28 Bayer Pharma Aktiengesellschaft 2-methyl-quinazolines
WO2019201848A1 (en) 2018-04-18 2019-10-24 Bayer Pharma Aktiengesellschaft 2-methyl-aza-quinazolines
CN108689901B (zh) * 2018-05-05 2020-04-28 西北大学 一种氮杂环丙烯类化合物的合成方法
JPWO2020017569A1 (ja) 2018-07-17 2021-12-02 日本ケミファ株式会社 Ｔ型カルシウムチャネル阻害剤
EP3950059A4 (en) 2019-03-29 2023-01-11 Nippon Chemiphar Co., Ltd. USE OF T-TYPE CALCIUM CHANNEL BLOCKERS FOR THE TREATMENT OF PRURITIS
EP3956446A1 (en) 2019-04-17 2022-02-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of nlrp3 inflammasome mediated il-1beta dependent disorders
WO2021198511A1 (en) 2020-04-03 2021-10-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of sars-cov-2 infection
WO2022008597A1 (en) 2020-07-08 2022-01-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical composition for the treatment of infectious diseases
CA3198468A1 (en) * 2020-10-30 2022-05-05 Daiichi Sankyo Company, Limited Production method for 3-methyl-4-haloindole derivatives
WO2023164612A1 (en) * 2022-02-25 2023-08-31 Nalo Therapeutics Modulators of myc family proto-oncogene protein

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4922539B2 (ja) 2000-09-15 2012-04-25 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼインヒビターとして有用なピラゾール化合物
US6613776B2 (en) 2000-09-15 2003-09-02 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6610677B2 (en) 2000-09-15 2003-08-26 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US7473691B2 (en) 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
NZ526470A (en) 2000-12-21 2006-03-31 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors
GB0128134D0 (en) 2001-11-23 2002-01-16 Syngenta Participations Ag A product for use in agriculture or horticulture
DK1663242T3 (da) 2003-08-07 2011-08-01 Rigel Pharmaceuticals Inc 2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler
MY141220A (en) * 2003-11-17 2010-03-31 Astrazeneca Ab Pyrazole derivatives as inhibitors of receptor tyrosine kinases
EP1763514A2 (en) 2004-05-18 2007-03-21 Rigel Pharmaceuticals, Inc. Cycloalkyl substituted pyrimidinediamine compounds and their uses
EP1841760B1 (en) * 2004-12-30 2011-08-10 Exelixis, Inc. Pyrimidine derivatives as kinase modulators and method of use
EP1877057A1 (en) 2005-04-27 2008-01-16 AstraZeneca AB Use of pyrazolyl-pyrimidine derivatives in the treatment of pain
JP2008540622A (ja) * 2005-05-16 2008-11-20 アストラゼネカ アクチボラグ 化合物
DK1945631T3 (da) * 2005-10-28 2012-10-22 Astrazeneca Ab 4- (3-aminopyrazole) pyrimidinderivater til anvendelse som tyrosinkinaseinhibitorer til behandling af cancer
EP1951715B1 (en) 2005-11-03 2013-09-04 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
WO2007059299A1 (en) 2005-11-16 2007-05-24 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
CA2656290A1 (en) 2006-07-05 2008-01-10 Exelixis, Inc. Methods of using igf1r and abl kinase modulators
EP2152694A2 (en) 2007-05-02 2010-02-17 Vertex Pharmaceuticals Incorporated Thiazoles and pyrazoles useful as kinase inhibitors
CN101687852A (zh) 2007-05-24 2010-03-31 沃泰克斯药物股份有限公司 可用作激酶抑制剂的噻唑类和吡唑类化合物
JP2011511005A (ja) * 2008-02-04 2011-04-07 オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド ２−アミノピリジン系キナーゼ阻害薬
CN102811619B (zh) * 2009-11-13 2015-04-22 金纳斯克公司 激酶抑制剂
RU2014129740A (ru) * 2011-12-22 2016-02-10 Ф.Хоффманн-Ля Рош Аг Производные 2,4-диаминопиримидина в качестве ингибиторов серин/треонин киназы

Also Published As

Publication number Publication date
CA2844729A1 (en) 2013-02-28
RU2014109897A (ru) 2015-09-27
KR20140062079A (ko) 2014-05-22
WO2013026914A1 (en) 2013-02-28
US8637537B2 (en) 2014-01-28
US20130225620A1 (en) 2013-08-29
EP2748159A1 (en) 2014-07-02
BR112014003997A2 (pt) 2017-03-21
MX2014002208A (es) 2014-05-28
CN104024248A (zh) 2014-09-03
JP2014524456A (ja) 2014-09-22

Similar Documents

Publication Publication Date Title
HK1254429A1 (zh) 絲氨酸/蘇氨酸激酶抑制劑
HK1197232A1 (en) Serine/threonine pak1 inhibitors / pak1
HK1200828A1 (en) Kinase inhibitors
HK1200371A1 (en) Neprilysin inhibitors
EP2734529A4 (en) BTK INHIBITORS
EP2683693A4 (en) ROR-GAMMA-T INHIBITORS
IL227399A0 (en) Novel azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
EP2710007A4 (en) Kinase Inhibitors
IL229028A0 (en) Kinase inhibitors
HK1211574A1 (en) Serine threonine kinase inhibitors
HK1199873A1 (en) Kinase inhibitors
GB201120474D0 (en) Inhibitors
GB201104399D0 (en) Novel inhibitors